Read + Share
Chhablani J, Jager R, Ong J, Lohrenz R, et al. Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for
treatment-resistant nAMD. Graefes Arch Clin Exp Ophthalmol 2022;260:3791-3798.
PMID: 35713709
|
 |
|
Chhablani J, Jager R, Ong J, Lohrenz R, et al. Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for
treatment-resistant nAMD. Graefes Arch Clin Exp Ophthalmol 2022;260:3791-3798.
PMID: 35713709
|
|
|
|